3M New Ventures on Renewable Energy Investing

3M New Ventures on Renewable Energy Investing

by Chris Miller

Sebastian Titz, from the corporate VC arm of 3M, talks to MIT Entrepreneurship Review about new investment opportunities renewable energy and makes the bold claim that renewable energy, aside from wind and solar, will not happen in the next 30 years

Chris Miller

Prior to enrolling in MIT Sloan, Chris was developing extensive experience in sales and marketing. He began his career as a retail broker regularly making 300 cold calls a day, which allowed him to build a book of business as one of the youngest salesmen in the firm. While there he also created a sales-training manual detailing techniques and procedures for establishing new client relationships, that was used for training...

Lower-Cost Models Will Drive the Negative Pressure Wound Therapy Market

Lower-Cost Models Will Drive the Negative Pressure Wound Therapy Market

by Joshua Copp

Healthcare reform in the United States has prompted a closer look at costs across the entire value chain. Ultimately, those companies that provide equivalent products and services at lower cost will gain dominance their respective markets. In the case of Negative Pressure Wound Therapy, lower-cost innovations will drive the market’s growth in the next several years.

Joshua Copp

Josh Copp is a 2012 MBA Candidate at MIT Sloan. His interests lie in the biomedical, medical device and technology spaces, with specific interests in how one can adapt cognitive theory into viable commercial applications. He received his B.A., cum laude, in Applied Mathematics from Harvard University, where he focused his studies on Neuroscience. Prior to matriculating at MIT Sloan, he worked for the Boston Consulting Group...

For Every 3 Things We Try, At Least 2 Will Fail

For Every 3 Things We Try, At Least 2 Will Fail

by Albert Ching

After 4 months of research and development, this was the moment we had been waiting for - a twelve-year old kid in Phnom Penh grinning widely and listening to our first audio story shared on Cambodian soil, Ratha’s Dengue Fever, a cautionary tale about the consequences of not sleeping in a bednet at night.  ...

Albert Ching

Born and raised in Waikiki, Albert is enduring the freezing cold in Cambridge to pursue his Masters in City Planning at MIT. While at MIT, Albert is a research assistant in the future of Singapore mobility project and hopes to continue his passion for developing solutions for those who need it most (like the children of Cambodia). He comes from 5 years working in finance at Google, supporting the initial launches of Google...

iPhone, iPad, iFund!

iPhone, iPad, iFund!

by Akash Bhatia

Steve Jobs unveiled the new iPad 2 on March 10, 2011. On March 11, there were endless lines of customers waiting outside Apple stores across the US with their credit cards ready.  Apple is re-defining computing with its unique devices and App store. With over 350,000 iPhone apps and over 65,000 apps for the iPad, the App store has fast become an unparalleled release medium for mobile software...

Akash Bhatia

Akash is a first year MBA student at MIT Sloan School of Management. Prior to Sloan, Akash Co-founded India's first and largest entertainment and sports ticketing company, KyaZoonga (http://www.kyazoonga.com). Launched in 2007, KyaZoonga has quickly become the go-to destination for tickets to cricket, movies, concerts and live events in India. KyaZoonga is also the official ticketing partner of the ICC Cricket World Cup in...

Navigating Biotech Adolescence

Navigating Biotech Adolescence

by Jordi Mata-Fink

Much changes when a biotech start-up becomes a mid-sized company. But how to maintain the creativity and spark of the early days to spur the next generation of drugs into the pipeline? In an interview with MITER, Merrimack’s Ulrik Nielsen discusses the challenge of sustaining innovation when a biotech start-up grows up.

Jordi Mata-Fink

Jordi is a PhD student in chemical engineering at MIT. His thesis research applies the tools of protein engineering to vaccine development. He is interested in biotech entrepreneurship, healthcare delivery and policy, and global health.

Innovation in Pharma Part IV: What comes next?

Innovation in Pharma Part IV: What comes next?

by Jordi Mata-Fink

In the fourth of a four-part series, we explore what a new, nimble, more innovative pharma sector might look like. How bad are the shrinking pains? What's next for the industry? Join us on Wednesday, April 4th, 11:30am at the MIT Trust Entrepreneurship Center (E40-160B) for a discussion on "Entrepreneurial Big Pharma: Myth or Reality?"

Click for...

Jordi Mata-Fink

Jordi is a PhD student in chemical engineering at MIT. His thesis research applies the tools of protein engineering to vaccine development. He is interested in biotech entrepreneurship, healthcare delivery and policy, and global health.

Instagram VCs are celebrating their own obituary

Instagram VCs are celebrating their own obituary

by Stav Davis

One billion dollars. 100% leveraging in one week. 280X for Andreesen-Horowitz, the venture capital firm which invested $250,000 in Instagram in 2010. So many records have been broken by the Facebook acquisition of Instagram and these are records that will be very hard to break in the future. No doubt, this is Silicon Valley’s venture capitalists most glorious moment (those who are not crying over missing this...

Stav Davis

Stav is an MBA candidate at MIT-Sloan School of Management, Entrepreneurship & Innovation Track. He is a biomedical engineer by profession but has a diverse background that ranges from founding a neuro startup and a nanotech startup to writing and producing independent films. He is now focused on energy entrepreneurship, design thinking, robotics and anything that can elegantly improve the world.

Starting a Company Right Out of MIT - An Interview with the Founder of Hipmunk

Move over Alvin and friends, there’s a new popular chipmunk to reckon with: the mascot of a flight search startup called Hipmunk, co-founded by fresh-faced MIT graduate Adam Goldstein (Class of 2010, Course 6 – Electrical Engineering and Computer Science). The idea came to Goldstein during his extensive travel as a member of the MIT debate team. Finding flights was a difficult endeavor. Simply put, he thought “it [the experience] sucked.”

Want to be a Cleantech Entrepreneur? Be Creative in Your Commercialization Strategies

Article Image

Many entrepreneurs agree that clean energy technology has technology commercialization challenges--capital investments required are usually large, scaling takes a relatively long time, and regulatory policies are uncertain. In today’s lean economic climate, what alternative strategies should entrepreneurs look for to bring their technology to successful commercialization?

Instagram VCs are celebrating their own obituary

Article Image

One billion dollars. 100% leveraging in one week. 280X for Andreesen-Horowitz, the venture capital firm which invested $250,000 in Instagram in 2010. So many records have been broken by the Facebook acquisition of Instagram and these are records that will be very hard to break in the future. No doubt, this is Silicon Valley’s venture capitalists most glorious moment (those who are not crying over missing this bonanza, at least). But should they be celebrating?

Emerging Trends in Natural Gas – Finding New Sources of Demand

Article Image

 

The recent advent of shale gas has disrupted the U.S. energy market, causing entrepreneurs to jump on what many consider a once-in-a-generation opportunity.  Money has begun chasing natural gas deals including professional investors such as Venture Capital and Private Equity firms all the way down to the retail investor.  Some of hottest stocks this year have been companies that are capitalizing on cheap natural gas. In this article, we take a look at some of the most exciting firms in the space today.

 

Big Data in the Big Apple: Thoughts from GigaOm's Structure:Data Conference

Article Image

Economic expansion works like this: One trigger innovation spawns a number of supporting industries. The automobile, for example, brought us service stations, fast food chains, asphalt and suburban homes. Steel is another great example; the sturdy and affordable metal birthed the age of modern infrastructure.

Today, the world of web and mobile services has spawned a new and booming industry. The industry is called “Big Data,” and last week the key players got together in New York City at the GigaOM Structure:Data Conference.

Innovation in Pharma Part IV: What comes next?

Article Image

In the fourth of a four-part series, we explore what a new, nimble, more innovative pharma sector might look like. How bad are the shrinking pains? What's next for the industry? Join us on Wednesday, April 4th, 11:30am at the MIT Trust Entrepreneurship Center (E40-160B) for a discussion on "Entrepreneurial Big Pharma: Myth or Reality?"

Click for Part I -- Part II -- Part III -- Part IV

Innovation in Pharma Part III: Turning biotech relationships from zero-sum to win-win-win

Article Image

Biotechs get bought by pharmaceutical companies every day. Now imagine the inverse. What if pharma was the one spinning out innovative small companies? And what if everybody won? In the third of a four-part series on innovation in pharma, we examine a rethought relationship between Pfizer and biotech. Join us on Wednesday, April 4th, 11:30am at the MIT Trust Entrepreneurship Center (E40-160B) for a discussion on "Entrepreneurial Big Pharma: Myth or Reality?"

Click for Part I -- Part II -- Part III -- Part IV